Status:
NOT_YET_RECRUITING
A Diagnostic Nomogram for Predicting Vaginal Invasion in Cervical Cancer
Lead Sponsor:
Fujian Cancer Hospital
Conditions:
Cervix Carcinoma
Eligibility:
FEMALE
18-80 years
Brief Summary
This study aims to develop a diagnostic nomogram based on clinical factors with the prediction values of vaginal invasion in cervical cancer to optimize the treatment plan and surgical procedures.
Detailed Description
Vaginal invasion is a crucial index participant in cervical cancer tumor staging and prognosis prediction. However, the roles of vaginal invasion are overlooked in the literature, compared with those ...
Eligibility Criteria
Inclusion
- Pathologically confirmed cervical cancer;
- FIGO2018 stage IB-IIA according to the result of physical examination and images;
- No preoperative treatment before surgery;
- Abdominal MRI is performed within three weeks before surgery. Blood routine, biochemistry, blood tumor markers and coagulation function were examined within 1 week before surgery.
- All patients undergo radical hysterectomy (RH) with bilateral pelvic lymphadenectomy or paraaortic lymph node dissection.
Exclusion
- Accompanied with other tumors;
- Accompanied with chronic infectious and immune diseases;
- Incomplete clinical data.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06039982
Start Date
November 1 2023
End Date
November 1 2026
Last Update
September 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fujian Cancer Hospital
Fuzhou, Fujian, China, 350014